University of Colorado Denver School of Medicine Barbara Davis Center
Welcome,         Profile    Billing    Logout  
 13 Trials 
12 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mauras, Nelly
NCT04020913: Skeletal Muscle Effects of GH in Boys

Active, not recruiting
N/A
45
US
Somatropin injection, Recombinant Growth Hormone, Norditropin
Nemours Children's Clinic, Novo Nordisk A/S
Growth Hormone Deficiency, Idiopathic Short Stature
03/25
07/25
DiMeglio, Linda A
INHALE-1, NCT04974528: Afrezza® Study in Pediatrics

Active, not recruiting
3
319
US
Afrezza, Technosphere Insulin, Rapid-acting Insulin Analog, insulin aspart, insulin lispro, insulin glulisine, Novolog®, Fiasp®, Humalog®, Admelog®, Apidra®, Basal Insulin, insulin glargine, insulin degludec, insulin detemir, Lantus®, Abasaglar®, Basaglar®, Semglee®, Toujeo®, Tresiba®, Levemir®
Mannkind Corporation, Jaeb Center for Health Research
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
10/24
05/25
NCT05378672: A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D

Recruiting
3
8
US
Dasiglucagon, Zegalogue, ZP4207
Zealand Pharma, Novo Nordisk A/S
Hypoglycemia, Type 1 Diabetes
09/24
09/24
TADPOL, NCT05594563: TArgeting Type 1 Diabetes Using POLyamines

Recruiting
2
70
US
DFMO, Difluoromethylornithine, Placebo
Emily K. Sims, Juvenile Diabetes Research Foundation, Cancer Prevention Pharmaceuticals, Inc.
Type 1 Diabetes
12/27
12/27
RescuiNGkids, NCT04992312 / 2021-006088-61: A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes

Completed
1
7
US
Glucagon Nasal Powder [Baqsimi], LY900018, Baqsimi
Eli Lilly and Company, Eli Lilly and Company
Type 1 Diabetes
11/23
11/23
TOPPLE T1D, NCT04279613: A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

Completed
1
47
US
NNC0361-0041, Placebo
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Novo Nordisk A/S
Type I Diabetes
08/23
04/24
NCT05403502: Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes

Completed
N/A
183
US
t:slim X2 insulin pump with Control-IQ technology 1.5
Tandem Diabetes Care, Inc., Eli Lilly and Company, Jaeb Center for Health Research
Type 1 Diabetes
08/23
08/23
Wadwa, Paul
NCT06449677: Bionic Pancreas in CFRD

Recruiting
3
150
US
iLet Bionic Pancreas System (BP), Usual Care (UC)
Jaeb Center for Health Research, Cystic Fibrosis Foundation, Massachusetts General Hospital, Beta Bionics, Inc.
Cystic Fibrosis-related Diabetes
11/25
03/26
Criego, Amy
NCT05714059: Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Completed
N/A
250
US
Insulin Pump with Continuous Glucose Monitoring
Medtronic Diabetes
Type 1 Diabetes
12/23
12/23
Raymond, Jennifer
NCT03142152: The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Recruiting
N/A
300
Europe, US
Carillon Mitral Contour System, Carillon, Percutaneous mitral valve repair, Guideline Directed Heart Failure Medication
Cardiac Dimensions, Inc.
Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases, Cardiovascular Diseases, Heart Valve Diseases
12/26
12/30
Randell, Tabitha
NCT05189938: HbA1c Variation Study

Completed
N/A
488
Europe, US
HBA1c data and glucose levels
Abbott Diabetes Care
Diabetes Mellitus
12/23
12/23
RADIANT, NCT05923827: Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults

Active, not recruiting
N/A
200
Europe
Omnipod 5 System
Insulet Corporation
Diabetes Mellitus, Type 1
08/24
08/25
Denvir, Louise
No trials found

Download Options